Ticker name:AMRN AMARIN CORP PLCUK
Country: IE-Sector: Healthcare, Industry: Biotechnology
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
- CEO: Aaron D. Berg
- IPO: Apr 01, 1993
- Website:amarincorp.com (open a new tab)
Market Cap 292M
Last close 13.93$
Floor clearance 12.98%
Floor clearance (Past 30d)46.8%
Price Return
- 90d
- -0.92%
- YTD
- -0.18%
- 1Y
- 17.55%
- 3Y
- -44.72%
- 5Y
- -85.37%
Key metrics
Largest 20 companies In Biotechnology
| # Position | Ticker | Company Name | Market Cap | Last Price | Action |
|---|---|---|---|---|---|
| 1 | VRTX | VERTEX PHARMACEUTICALS INC / MA | 113B | 446.83$ | |
| 2 | REGN | REGENERON PHARMACEUTICALS, INC. | 67B | 635.45$ | |
| 3 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | 40B | 303.05$ | |
| 4 | RPRX | Royalty Pharma plc | 32B | 55.87$ | |
| 5 | RVMD | Revolution Medicines, Inc. | 32B | 149.23$ | |
| 6 | UTHR | UNITED THERAPEUTICS Corp | 23B | 549.87$ | |
| 7 | ROIV | Roivant Sciences Ltd. | 21B | 28.58$ | |
| 8 | INCY | INCYTE CORP | 20B | 102.38$ | |
| 9 | INSM | INSMED Inc | 20B | 94.22$ | |
| 10 | MRNA | Moderna, Inc. | 19B | 47.44$ | |
| 11 | NBIX | NEUROCRINE BIOSCIENCES INC | 16B | 163.88$ | |
| 12 | GMAB | GENMAB A/S | 16B | 25.15$ | |
| 13 | JAZZ | Jazz Pharmaceuticals plc | 15B | 238.57$ | |
| 14 | EXEL | EXELIXIS, INC. | 13B | 52.7$ | |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13B | 67.61$ | |
| 16 | ASND | Ascendis Pharma A/S | 13B | 210.45$ | |
| 17 | IONS | IONIS PHARMACEUTICALS INC | 12B | 74.48$ | |
| 18 | AXSM | Axsome Therapeutics, Inc. | 12B | 232.32$ | |
| 19 | SMMT | Summit Therapeutics Inc. | 11B | 14.77$ | |
| 20 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | 11B | 486.98$ |